GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chengdu Easton Biopharmaceuticals Co Ltd (SHSE:688513) » Definitions » Days Payable

Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Days Payable : 255.45 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Chengdu Easton Biopharmaceuticals Co Days Payable?

Chengdu Easton Biopharmaceuticals Co's average Accounts Payable for the three months ended in Mar. 2024 was ¥178 Mil. Chengdu Easton Biopharmaceuticals Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥64 Mil. Hence, Chengdu Easton Biopharmaceuticals Co's Days Payable for the three months ended in Mar. 2024 was 255.45.

The historical rank and industry rank for Chengdu Easton Biopharmaceuticals Co's Days Payable or its related term are showing as below:

SHSE:688513' s Days Payable Range Over the Past 10 Years
Min: 61.13   Med: 220.1   Max: 415.97
Current: 261.91

During the past 8 years, Chengdu Easton Biopharmaceuticals Co's highest Days Payable was 415.97. The lowest was 61.13. And the median was 220.10.

SHSE:688513's Days Payable is ranked better than
63.95% of 724 companies
in the Biotechnology industry
Industry Median: 150.695 vs SHSE:688513: 261.91

Chengdu Easton Biopharmaceuticals Co's Days Payable declined from Mar. 2023 (292.82) to Mar. 2024 (255.45). It may suggest that Chengdu Easton Biopharmaceuticals Co accelerated paying its suppliers.


Chengdu Easton Biopharmaceuticals Co Days Payable Historical Data

The historical data trend for Chengdu Easton Biopharmaceuticals Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengdu Easton Biopharmaceuticals Co Days Payable Chart

Chengdu Easton Biopharmaceuticals Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial 164.09 302.32 415.97 335.92 276.11

Chengdu Easton Biopharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 292.82 310.19 247.29 243.48 255.45

Competitive Comparison of Chengdu Easton Biopharmaceuticals Co's Days Payable

For the Biotechnology subindustry, Chengdu Easton Biopharmaceuticals Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chengdu Easton Biopharmaceuticals Co's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chengdu Easton Biopharmaceuticals Co's Days Payable distribution charts can be found below:

* The bar in red indicates where Chengdu Easton Biopharmaceuticals Co's Days Payable falls into.



Chengdu Easton Biopharmaceuticals Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Chengdu Easton Biopharmaceuticals Co's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (156.859 + 180.938) / 2 ) / 223.274*365
=168.8985 / 223.274*365
=276.11

Chengdu Easton Biopharmaceuticals Co's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

Days Payable (Q: Mar. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2023 ) + Accounts Payable (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (180.938 + 174.899) / 2 ) / 63.554*365 / 4
=177.9185 / 63.554*365 / 4
=255.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chengdu Easton Biopharmaceuticals Co Days Payable Related Terms

Thank you for viewing the detailed overview of Chengdu Easton Biopharmaceuticals Co's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Xiyuan Avenue, Chengdu High-tech Zone, Sichuan Province, Chengdu, CHN, 611731
Chengdu Easton Biopharmaceuticals Co Ltd is engaged in research and development, production and sales of chemical raw materials and chemical pharmaceutical preparations. The company's products range from Active Pharmaceutical Ingredient to finish dosage forms like capsules, tablets and injections, enabling us to take R&D discovery to industrial level, solving problems during the course of R&D, production and distribution. Its products are categorized under Active Pharmaceutical Ingredients and Fixed Dose Formulation.

Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Headlines

No Headlines